INA-RESPOND conducts research and capacity-building activities to generate scientific evidence supporting infectious disease control and evidence-based health policy.
INA-RESPOND conducts research and capacity-building activities to generate scientific evidence supporting infectious disease control and evidence-based health policy.
Research focuses on infectious diseases that are national health priorities in Indonesia and have regional and global impact, including tuberculosis, HIV/AIDS, COVID-19, pneumonia, sepsis, tropical diseases, and acute febrile illnesses.
INA-RESPOND conducts multicenter clinical studies including observational cohort studies and clinical trials, aiming to understand disease epidemiology, evaluate treatment effectiveness, and develop improved diagnostic and therapeutic approaches.
INA-RESPOND supports research through the development of a reference laboratory with advanced diagnostic capacity for various infectious disease pathogens. The laboratory also processes research specimens and supports outbreak investigations.
INA-RESPOND develops research data management systems that enable standardized collection, processing, and analysis of clinical data across multiple research sites.
INA-RESPOND manages a biorepository that stores biological specimens from various studies, enabling further analysis and supporting national and international research collaborations.